ADAG

Adagene Inc. American Depositary Shares

$2.29

Current Price

All

AI analysis

Read what the AI thinks of Adagene Inc. American Depositary Shares in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$0.30

P/E

—

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Posts

No posts about ADAG yet.

About Adagene Inc. American Depositary Shares

Adagene is a clinical-stage biotechnology company based in China that develops antibody-based cancer medicines. Its platform designs antibodies meant to switch on mainly inside tumors, which aims to cut side effects in healthy tissue. The company has almost no product sales. It funds its work through partnership payments from larger drug makers and by selling shares to investors.